• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.57 Down 0.02(3.13%) Feb 27, 4:03PM EST
    Add to Portfolio
    Prev Close:0.59
    Open:0.59
    Bid:0.58 x 200
    Ask:0.59 x 300
    1y Target Est:3.50
    Beta:1.39
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:0.57 - 0.60
    52wk Range:0.53 - 1.46
    Volume:681,899
    Avg Vol (3m):624,675
    Market Cap:35.75M
    P/E (ttm):N/A
    EPS (ttm):-0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 3.13%35.75M
    AGENDown 2.78%307.15M
    DNDN 0.00%N/A
    STMLDown 6.23%196.85M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.17
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback